On December 30, 2024, the Massachusetts state legislature passed House Bill 4653 (the Act), which significantly enhances ...

JMP Securities has recently raised Sabra Health Care REIT Inc (SBRA) stock to Mkt Outperform rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 5, 2024, Mizuho had ...

Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from ...

Health Care REITs LTC Properties (LTC) and Sabra Health Care REIT (SBRA) were upgraded at JMP, citing multiple tailwinds are ...

JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple ...

In a report released today, Aaron Hecht from JMP Securities upgraded Sabra Healthcare REIT (SBRA – Research Report) to a Buy, with a price ...

Sabra Health Care REIT rated buy, undervalued compared to peers. Investment-grade ratings, +7% dividend yield opportunity.

Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part ...

Jefferies lowered the firm’s price target on National Health Investors (NHI) to $66 from $77 and keeps a Hold rating on the ...

JPMorgan Chase & Co. lifted its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 222.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 9,886,917 ...

On Tuesday, Sabra Health Care REIT Inc (SBRA) stock saw a modest uptick, ending the day at $17.32 which represents a slight increase of $0.28 or 1.64% from the prior close of $17.04. The stock opened ...

Jenny Van Leeuwen Harrington of Gilman Hill Asset Management picked Sabra Health Care REIT, Inc. as her final trade.